Drug interactions update: Drugs, herbs, and oral anticoagulation

被引:40
作者
Wittkowsky, AK
机构
[1] Univ Washington, Med Ctr, Dept Pharm, Anticoagulat Serv, Seattle, WA 98195 USA
[2] Univ Washington, Sch Pharm, Seattle, WA 98195 USA
关键词
warfarin; anticoagulation; drug interactions; herbal medicinals;
D O I
10.1023/A:1012742628628
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Management of warfarin drug interactions is often complicated by lack of information regarding interactions with new drugs and with herbal medicinals. The pharmaceutical industry has increased both the number and quality of drug interaction studies prior to marketing new agents. Interactions may still occur in patients, however, despite negative pre-marketing studies in healthy volunteers. The clinical significance and intensity of warfarin interactions with prescription drugs (e.g., celecoxib, proton pump inhibitors, and selective serotonin reuptake inhibitors) can often be predicted on the basis of known metabolic characteristics of the drugs and warfarin enantiomers. Drug interactions with herbal medicinals are much more difficult to characterize and predict because of the lack of federal regulations regarding safety, efficacy, and manufacturing standards. Published case reports of interactions between warfarin and even the most widely used herbal medicinals are limited. Practitioners are encouraged to report such interactions through the FDA MedWatch program.
引用
收藏
页码:67 / 71
页数:5
相关论文
共 22 条
[1]  
AHMAD S, 1991, SOUTHERN MED J, V84, P674
[2]   Pharmacokinetics, metabolism and interactions of acid pump inhibitors - Focus on omeprazole, lansoprazole and pantoprazole [J].
Andersson, T .
CLINICAL PHARMACOKINETICS, 1996, 31 (01) :9-28
[3]   Safety issues with herbal medicine [J].
Boullata, JI ;
Nace, AM .
PHARMACOTHERAPY, 2000, 20 (03) :257-269
[4]   Antidepressant interactions with warfarin [J].
Duncan, D ;
Sayal, K ;
McConnell, H ;
Taylor, D .
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 1998, 13 (02) :87-94
[5]   Trends in alternative medicine use in the United States, 1990-1997 - Results of a follow-up national survey [J].
Eisenberg, DM ;
Davis, RB ;
Ettner, SL ;
Appel, S ;
Wilkey, S ;
van Rompay, M ;
Kessler, RC .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 280 (18) :1569-1575
[6]  
Haase KK, 2000, ANN PHARMACOTHER, V34, P666
[7]   Potential interactions between alternative therapies and warfarin [J].
Heck, AM ;
DeWitt, BA ;
Lukes, AL .
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2000, 57 (13) :1221-1227
[8]   Probable interaction between warfarin and ginseng [J].
Janetzky, K ;
Morreale, AP .
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 1997, 54 (06) :692-693
[9]   Celecoxib does not significantly alter the pharmacokinetics or hypoprothrombinemic effect of warfarin in healthy subjects [J].
Karim, A ;
Tolbert, D ;
Piergies, A ;
Hubbard, RC ;
Harper, K ;
Wallemark, CB ;
Slater, M ;
Geis, GS .
JOURNAL OF CLINICAL PHARMACOLOGY, 2000, 40 (06) :655-663
[10]   Unsafe and potentially safe herbal therapies [J].
Klepser, TB ;
Klepser, ME .
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 1999, 56 (02) :125-138